BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6133217)

  • 1. [Combined treatment of arterial hypertension. Comparison of a beta-blocker plus a saluretic combination with beta-blocker].
    Rodatz KW; Hörder MH
    MMW Munch Med Wochenschr; 1983 Feb; 125(7):136-8. PubMed ID: 6133217
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nadolol + bendroflumethiazide in a fixed combination and in sequential administration. Experimental research on antihypertensive efficacy and tolerability].
    Del Re ML; Ricci A; Abate G
    Clin Ter; 1986 Mar; 116(5):385-90. PubMed ID: 2871962
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of the nadolol-bendroflumethiazide combination in the treatment of arterial hypertension].
    Zecchi P; Bellocci F; Santarelli P; Iannarelli M
    Clin Ter; 1986 Jan; 116(1):19-24. PubMed ID: 2870837
    [No Abstract]   [Full Text] [Related]  

  • 4. [Field study: long-term antihypertensive therapy with the beta blocker nadolol in a once-a-day dosage - an outpatient study of Swiss medical practices].
    Bertel O; Conen D; Renggli I
    Schweiz Rundsch Med Prax; 1983 Feb; 72(8):264-8. PubMed ID: 6132374
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the antihypertensive effect and tolerability of nadolol administered alone or in association with bendroflumethiazide].
    Gragnoli G; Righi GA; Turchetti V; Mondillo S; Kristodhullu A
    Minerva Med; 1984 Nov; 75(43):2609-15. PubMed ID: 6392936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The treatment of ambulant hypertensive patients with a combination of a saluretic and a beta-receptor blocker (author's transl)].
    Schlesinger P; Fadel Tabet F
    MMW Munch Med Wochenschr; 1981 Oct; 123(42):1589-92. PubMed ID: 6118831
    [No Abstract]   [Full Text] [Related]  

  • 7. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
    Jackson DA
    Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL
    Ugeskr Laeger; 1975 Sep; 137(39):2274-6. PubMed ID: 241148
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
    Ostapiuk FE; Khvoĭnitskiĭ VA
    Sov Med; 1984; (5):87-9. PubMed ID: 6147019
    [No Abstract]   [Full Text] [Related]  

  • 10. Nadolol (Corgard) - a new beta-blocker.
    Med Lett Drugs Ther; 1980 Apr; 22(8):33-4. PubMed ID: 6102734
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nadolol, a long-acting beta-blocker, in the treatment of essential arterial hypertension].
    Semplicini A; Pessina AC; Rossi GP; Tagliafierro R; Lusiani L; Castellani V; Bedogni F; Mazzucato A; Ronsisvalle G
    Cardiologia; 1982 Sep; 27(9):853-64. PubMed ID: 6765448
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydrochlorothiazide and nadolol in the treatment of hypertension.
    Olerud B
    Practitioner; 1982 Apr; 226(1366):785-7. PubMed ID: 7045854
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
    Marchetta F; Chiarini C; Degli Esposti E; Santoro A; Sturani A; Zuccalà A; Zucchelli P
    Clin Ter; 1983 Aug; 106(3):209-12. PubMed ID: 6627892
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of essential hypertension. A comparison between nadolol, once daily, and propranolol, four times daily.
    Frithz G
    Practitioner; 1982 Mar; 226(1365):562-4. PubMed ID: 7045847
    [No Abstract]   [Full Text] [Related]  

  • 15. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of beta blockers combined with thiazides on serum electrolytes].
    Djurhuus MS; Rohold A; Vadstrup S
    Ugeskr Laeger; 1989 Aug; 151(33):2076-8. PubMed ID: 2570476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nadolol in the preventive treatment of migraine].
    Szczudlik A
    Wiad Lek; 1984 Jul; 37(14):1087-92. PubMed ID: 6151319
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of betaxolol (Kerlone) as a once-daily treatment for hypertension in 4685 patients.
    Djian J
    Br J Clin Pract; 1985 May; 39(5):188-91. PubMed ID: 2866790
    [No Abstract]   [Full Text] [Related]  

  • 19. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
    Cherchi A; Sau F; Mercuro G; Seguro C; Lai O
    Clin Ter; 1985 May; 113(4):301-6. PubMed ID: 3893868
    [No Abstract]   [Full Text] [Related]  

  • 20. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
    O'Callaghan EG
    Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.